| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 738568-41-7 | 4-Methyl-2-(methylimino)-1-imidazolidinamine | C5H12N4 |
| 738575-71-8 | 4-Pyrimidinecarboximidamide | C5H6N4 |
| 738606-42-3 | Bempedoic acid impurity 13 | C20H38O5 |
| 738606-43-4 | 2,2,14,14-Tetramethyl-8-oxopentadecanedioic acid diethyl ester | C23H42O5 |
| 738606-44-5 | 8-Isocyano-2,2,14,14-tetramethyl-8-(4-tolylsulfonyl)pentadecanedioic acid diethyl ester | C31H49NO6S |
| 738606-46-7 | Bempedoic acid | C19H36O5 |
| 738606-64-9 | Bempedoic Acid Impurity 2 | C23H44O5 |
| 739336-26-6 | 2-Bromo-5-fluorophenylacetic acid | C8H6BrFO2 |
| 739363-49-6 | 3-(N,N-Diethylamino)-D-alanine | C7H16N2O2 |
| 739364-95-5 | 2-Methyl-pyrazolo[1,5-a]pyrimidine-6-carboxylic acid | C8H7N3O2 |
| 739365-30-1 | 4-Methylisoindoline | C9H11N |
| 739365-99-2 | (5-Methyl-1H-pyrazol-3-yl)carbamic acid phenylmethyl ester | C12H13N3O2 |
| 739366-03-1 | 5-(Methoxymethyl)-1H-pyrazol-3-amine | C5H9N3O |
| 739366-20-2 | Anagliptin | C19H25N7O2 |
| 740055-30-5 | (R)-alpha-Aminobenzenebutanoic acid 1,1-dimethylethyl ester | C14H21NO2 |
| 740061-36-3 | 3-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine | C7H11N3 |
| 740768-99-4 | 3-Azetidinecarboxamide | C4H8N2O |
| 740774-41-8 | (R)-4-Amino-3-(4-methoxyphenyl)butanoic acid | C11H15NO3 |
| 740780-79-4 | (1R,3'R)-Solifenacin | C23H26N2O2 |
| 740797-41-5 | 5-(Chloromethyl)-8-methoxyquinoline | C11H10ClNO |
| 740799-82-0 | 3,4-Dihydroxy-2-methylbenzoic acid methyl ester | C9H10O4 |
| 740810-42-8 | Cudratricusxanthone A | C23H24O6 |
| 740813-37-0 | Ethyl 5-bromopyrrole-2-carboxylate | C7H8BrNO2 |
| 740815-36-5 | (N-Phenylindol-2-yl)dicyclohexylphosphine | C26H32NP |
| 740815-37-6 | N-Phenyl-2-(di-tert-butylphosphino)indole | C22H28NP |
| 740842-50-6 | 2-Nitro-5,6,8,9-tetrahydrobenzocyclohepten-7-one | C11H11NO3 |
| 740842-73-3 | 1,1-Dimethylethyl 7-bromo-2,3-dihydro-1,4-benzoxazepine-4(5H)-carboxylate | C14H18BrNO3 |
| 740873-06-7 | Naluzotan | C23H38N4O3S |
| 741217-33-4 | (R)-4-Amino-3-(4-fluorophenyl)butanoic acid | C10H12FNO2 |
| 741253-03-2 | 6-Bromo-2-benzothiazolecarbonitrile | C8H3BrN2S |
| 741253-05-4 | Indole-3-boronic acid | C8H8BNO2 |
| 741276-43-7 | 4-Chloro-7-isopropoxy-6-methoxyquinoline-3-carbonitrile | C14H13ClN2O2 |
| 741287-46-7 | 1-Boc-4-Isopropylpiperazine | C12H24N2O2 |
| 741287-82-1 | 3-Methoxy-6-(hydrazino)pyridine | C6H9N3O |
| 741288-31-3 | (3S)-3-Morpholinecarboxylic acid methyl ester | C6H11NO3 |
| 741657-02-3 | Dehydroxy Vildagliptin | C17H25N3O |
| 741668-23-5 | (1R,2R,3R,4S)-Bicyclo[2.2.1]heptane-2,3-diamine | C7H14N2 |
| 741677-68-9 | 1-Butyl-3-methylimidazolium trifluoro(trifluoromethyl)borate | C8H15N2.CBF6 |
| 741686-49-7 | 2-(1H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-isoindole-1,3(2H)-dione | C14H8N4O2 |
| 741687-07-0 | tert-Butyl 4-amino-4-ethylpiperidine-1-carboxylate | C12H24N2O2 |
| 741699-04-7 | 3-Ethoxy-4-iodobenzoic acid ethyl ester | C11H13IO3 |
| 741705-70-4 | (alphaR,2R)-alpha-Phenyl-2-piperidineacetic acid hydrochloride | C13H17NO2.HCl |
| 741709-60-4 | 2-Ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | C13H20BNO2 |
| 741709-61-5 | 2-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | C13H20BNO2 |
| 741709-62-6 | 2-Cyanopyridine-4-boronic acid pinacol ester | C12H15BN2O2 |
| 741709-63-7 | 2-Cyanopyridine-5-boronic acid pinacol ester | C12H15BN2O2 |
| 741709-67-1 | 2-Chloro-3-(trifluoromethyl)pyridine-5-boronic acid pinacol ester | C12H14BClF3NO2 |
| 741713-40-6 | Ro 4584820 | C18H21F2N5O4S |
| 741721-51-7 | 3-Bromo-2,5-difluoronitrobenzene | C6H2BrF2NO2 |
| 741737-30-4 | tert-Butyl 2-methyl-3-oxopiperidine-1-carboxylate | C11H19NO3 |